These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20133470)

  • 1. Off-label use of recombinant igf-I to promote growth: is it appropriate?
    Rosenbloom AL; Rivkees SA
    J Clin Endocrinol Metab; 2010 Feb; 95(2):505-8. PubMed ID: 20133470
    [No Abstract]   [Full Text] [Related]  

  • 2. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
    Ranke MB; Wollmann HA; Savage MO
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans.
    Backeljauw PF; Chernausek SD
    Horm Res; 2006; 65 Suppl 1():21-7. PubMed ID: 16508330
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
    Collett-Solberg PF; Misra M;
    J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
    Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin-like growth factor-1 in Indian growth hormone-deficient children on growth hormone therapy.
    Ekbote VH; Rustagi VT; Khadilkar VV; Khadilkar AV; Chiplonkar SA
    Endocr Res; 2011; 36(3):109-15. PubMed ID: 21736493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
    Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.
    Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF)-I gene deletion.
    Camacho-Hübner C; Woods KA; Clark AJ; Savage MO
    Rev Endocr Metab Disord; 2002 Dec; 3(4):357-61. PubMed ID: 12424437
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I).
    Ranke MB
    Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):401-10. PubMed ID: 8853447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG
    Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
    Rosenbloom AL
    J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapentic efficacy of recombinant human growth hormone in postpuberal children with idiopathic short stature].
    Luo JM; He YQ; Liu M
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):208-10. PubMed ID: 24568920
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with Recombinant Human Insulin-Like Growth Factor-1 in Severe Primary IGF Deficiency and Beyond.
    Ranke MB
    Horm Res Paediatr; 2015; 83(5):358-60. PubMed ID: 25871890
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?
    Balhara B; Misra M; Levitsky LL
    Indian J Pediatr; 2012 Feb; 79(2):244-9. PubMed ID: 22090255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.